KRAS and colorectal carcinoma: In addition to the overall differential methylation analysis, we also evaluated the effects of age, gender, tumor stage, location of the tumor (colon or rectum), and the mutation status (KRAS + vs. KRAS-) of the CRC samples (Supplementary Tables 4–8).